ANARLO LIMITED

Company number 13814483 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ANARLO LIMITED - Analysis Report

Company Number: 13814483

Analysis Date: 2025-07-19 12:42 UTC

Financial Health Assessment for ANARLO LIMITED as of 31 December 2024


1. Financial Health Score: B

Explanation:
ANARLO LIMITED demonstrates solid financial footing with positive net current assets and shareholders' funds, indicating a generally healthy balance sheet. However, a noticeable decline in cash reserves over the past year and a reduction in net current assets suggest some caution. The company is not showing symptoms of distress but should monitor liquidity closely to maintain a healthy cash flow.


2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Cash at Bank 15,064 29,589 Cash reserves have halved, indicating potential cash flow tightening.
Current Liabilities 2,457 9,432 Significant reduction in short-term debts, a positive sign of managing payables.
Net Current Assets 12,607 20,157 Working capital remains positive but reduced, signaling less buffer for operations.
Total Assets less Current Liabilities 13,268 20,957 Reflects overall reduction in net assets, needing attention.
Shareholders' Funds 13,268 20,957 Positive equity but decreased, indicating retained earnings have been utilized or reduced.

Additional observations:

  • The company holds minimal fixed assets (£661), consistent with a consulting business model.
  • No employees reported, indicating a lean operational structure.
  • Directors’ current accounts and accrued expenses have decreased, reflecting better short-term financial management.

3. Diagnosis

ANARLO LIMITED is currently in a stable financial condition with a positive equity base and manageable liabilities. The "healthy cash flow" symptom is evident from positive working capital, but the sharp drop in cash reserves from £29,589 to £15,064 over the year is a "warning sign" of potential liquidity tightening. The company’s reduction in net assets and shareholders' funds could suggest either increased expenditure, investment in business development, or lower profitability. Since the company operates in engineering-related scientific and technical consulting, which typically requires low capital investment, the decline in cash is unlikely due to asset purchases but could indicate increased operational costs or delayed receivables.

The absence of employees may mean the company relies on directors or subcontractors, which could affect cash management and profitability dynamics.

No overdue filings and no indications of financial distress or insolvency proceedings are positive indicators of good governance and compliance.


4. Recommendations

To improve the financial wellness and prolong the company's healthy operation, consider the following actions:

  • Enhance Cash Flow Monitoring: Implement more rigorous cash flow forecasting to anticipate liquidity needs and avoid "cash flow disease."
  • Review Receivables and Payables: Accelerate collections from clients and manage payment terms with suppliers to maintain positive working capital.
  • Cost Control: Investigate areas where operating costs may be increasing and identify opportunities for cost reductions.
  • Profitability Analysis: Since retained earnings have decreased, review profit margins and pricing strategies to ensure sustainable profitability.
  • Build Cash Reserves: Aim to rebuild cash buffers to a level that can comfortably cover at least 3 months of operating expenses, providing a cushion against unforeseen expenses.
  • Engage with Financial Advisors: Periodic reviews with financial experts can help refine budgeting and financial strategies, ensuring the company remains on a healthy trajectory.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.